NeuraMedica Awarded $150k in grant funding from the Business Oregon SBIR/STTR Phase II Matching Grant Program

2 Minutes Read

Business Oregon’s SBIR/STTR Matching Grant Program Provides Funds for Production Process Development

Oregon City, Oregon, November 20, 2018 – NeuraMedica Inc. has been awarded a Business Oregon Small Business Innovation Research (SBIR) Phase II Matching Grant for $150,000. NeuraMedica received an SBIR Phase II grant in June 2018 through the National Institute of Health (NIH) for continued development of a novel bioabsorbable clip and applier for durotomy repair. The NIH Phase II grant provides funds for continued research and development activities but does not cover production tooling equipment or process development and validation for the dural clip. This Business Oregon Matching Grant will provide critical funds for final production tooling, bioabsorbable process development and optimization, efficiency studies, and cross machine validation, all of which are not covered by other funding sources.

NeuraMedica Inc. is honored to receive this SBIR Phase II Matching Grant through the Oregon Innovation Fund. This Matching Grant is funded in part with Oregon State Lottery funds administered by the Oregon Business Development Department (OBDD). In addition to this Matching Grant, NeuraMedica Inc. has received a National Science Foundation (NSF) SBIR Phase I grant, a Business Oregon SBIR Phase I Matching Grant, Gap funding through the Oregon Nanoscience and Microtechnologies Institute (ONAMI), and a Biomedical Innovation Program award through the Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science University (OHSU).

To learn more about the Business Oregon SBIR/STTR Matching Grant program, visit:

About the Business Oregon SBIR/STTR Matching Grant Program: As part of Oregon’s efforts to assist innovative companies and address gaps in federal SBIR/STTR programs, Business Oregon’s SBIR/STTR Matching Grant Program provides funding to help businesses build on projects and advance technologies developed using federal SBIR/STTR funds to help companies reach their next stage of growth. Business Oregon’s matching grants can be used on activities that cannot be covered by the federal SBIR/STTR grant funds and for things necessary for the company to move beyond the federally funded project and get closer to commercial production. The funds can be applied to expenses that help a company stay and grow in Oregon by furthering development of new technologies or products.

About NeuraMedica Inc.: NeuraMedica is a medical device company specializing in products for neurosurgery and other surgical specialties. NeuraMedica is located in Oregon City, Oregon and is a member of the growing medical device industry that now comprises over 700 Oregon-based, bioscience-related entities. NeuraMedica is both woman-owned and minority-owned (Native American) and is dedicated to contributing to the local economy by hiring the best candidates including those in underrepresented groups. The company was founded in 2014 by Biomedical Engineer Rachel Dreilinger (Co-founder and CEO) and Neurosurgeon Neil Roundy M.D. (Co-founder and Chief Medical Officer) to develop a straightforward solution to dural repair that benefits surgeons, hospitals, and patients. NeuraMedica aims to create a thriving company that is focused on commercializing devices for neurosurgery.

NeuraMedica Inc. Contact Information:
Contact: Rachel Dreilinger [Co-Founder and CEO]
Phone: 503.914.0723